[{"data":1,"prerenderedAt":60},["ShallowReactive",2],{"post-vacunas-gonorrea-clamidia-sifilis-resistencia-antimicrobiana":3},{"id":4,"documentId":5,"Title":6,"Author":7,"URL":8,"Publication_date":9,"Hashtags":10,"Content":11,"createdAt":12,"updatedAt":13,"publishedAt":14,"Summary":15,"title_Url":16,"specialty":17,"Image":18},222,"hrp64vz19xp1oz1h0ljp79m5","De las diferencias sexuales a las desigualdades sexuales en la esperanza de vida: Un análisis observacional comparativo entre países","Angela Y. Chang","https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004828","2025-12-11","#SaludPublica #Medicina #InvestigacionClinica #DesigualdadSexual #EsperanzaDeVida ","Las infecciones bacterianas de transmisión sexual representan un grave problema de salud pública. La investigación innovadora y el desarrollo acelerado de vacunas son cruciales, según Sami Gottlieb. Avances en vacunas contra gonorrea, clamidia y sífilis podría cambiar radicalmente el manejo de estas infecciones, especialmente en un contexto de creciente resistencia a los antimicrobianos.","2026-01-05T16:32:05.896Z","2026-01-22T04:13:42.255Z","2026-01-22T04:13:42.279Z","Las infecciones bacterianas de transmisión sexual continúan siendo un grave desafío de salud pública, agravado por el aumento de la resistencia a los antimicrobianos. Según expertos, el desarrollo acelerado de vacunas contra gonorrea, clamidia y sífilis podría transformar de manera radical la prevención y el manejo de estas infecciones. Los avances recientes en investigación vacunal ofrecen una oportunidad prometedora para reducir la carga global de estas enfermedades y limitar la dependencia de antibióticos en el futuro.","vacunas-gonorrea-clamidia-sifilis-resistencia-antimicrobiana","Enfermedades infecciosas",{"id":19,"documentId":20,"name":21,"alternativeText":22,"caption":22,"width":23,"height":23,"formats":24,"hash":55,"ext":28,"mime":29,"size":56,"url":57,"previewUrl":22,"provider":58,"provider_metadata":22,"createdAt":59,"updatedAt":59,"publishedAt":59},63,"zp8nk1qpo9i5vyto7ushi9u4","image.png",null,1024,{"thumbnail":25,"medium":34,"small":41,"large":48},{"name":26,"hash":27,"ext":28,"mime":29,"path":22,"width":30,"height":30,"size":31,"sizeInBytes":32,"url":33},"thumbnail_image.png","thumbnail_image_ac6a4d3c5d",".png","image/png",156,58.82,58820,"/uploads/thumbnail_image_ac6a4d3c5d.png",{"name":35,"hash":36,"ext":28,"mime":29,"path":22,"width":37,"height":37,"size":38,"sizeInBytes":39,"url":40},"medium_image.png","medium_image_ac6a4d3c5d",750,1130.47,1130467,"/uploads/medium_image_ac6a4d3c5d.png",{"name":42,"hash":43,"ext":28,"mime":29,"path":22,"width":44,"height":44,"size":45,"sizeInBytes":46,"url":47},"small_image.png","small_image_ac6a4d3c5d",500,527.39,527390,"/uploads/small_image_ac6a4d3c5d.png",{"name":49,"hash":50,"ext":28,"mime":29,"path":22,"width":51,"height":51,"size":52,"sizeInBytes":53,"url":54},"large_image.png","large_image_ac6a4d3c5d",1000,1846.32,1846323,"/uploads/large_image_ac6a4d3c5d.png","image_ac6a4d3c5d",424.01,"/uploads/image_ac6a4d3c5d.png","local","2026-01-05T16:32:05.556Z",1777183249274]